“It has been just over two years since Nasdaq’s listing bell rang at Medicon Village and Neola Medical entered the stock market. A lot has happened since then and the company’s focus is now all on preparing for market launch in the US. BioStock contacted Neola Medical’s CEO Hanna Sjöström to find out more about where the company is today and how she views the journey ahead.”

Do not miss BioStock’s latest article about Neola Medical with a longer interview with CEO Hanna Sjöström.

Read the full article here: BioStock – Neola Medical wants to revolutionise neonatal care